The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Perspective
PreviousPrevious
Volume 354:1665-1667 April 20, 2006 Number 16
NextNext

The NIH Budget and the Future of Biomedical Research
Joseph Loscalzo, M.D., Ph.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
Federal funding for biomedical research in the United States has fueled discoveries that have advanced our understanding of human disease, led to novel and effective diagnostic tools and therapies, and made our research enterprise an international paragon. Although it was not the original intent, this investment, through the National Institutes of Health (NIH), has also become an essential source of support for academic medical centers, providing funds for faculty and staff salaries, operational expenses, and even capital improvements related to research that can no longer be supported by clinical income. Until approximately 20 years ago, clinical income often subsidized research, . . . [Full Text of this Article]


Source Information

Dr. Loscalzo is the physician-in-chief and chair of medicine at Brigham and Women's Hospital and a professor of medicine at Harvard Medical School — both in Boston.


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.